NCT02954874 2026-03-17Testing MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast CancerNational Cancer Institute (NCI)Phase 3 Active not recruiting1,155 enrolled
NCT00445952 2018-02-01Natural History Study of Fungal Infections of the Blood in Patients With Cancer or in Patients Who Have Undergone a Stem Cell TransplantEuropean Organisation for Research and Treatment of Cancer - EORTCCompleted304 enrolled